Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia

Seung Gul Kang, Heon-Jeong Lee, Jung Eun Choi, Young Min Park, Jeong Hyun Park, Changsu Han, Yong Ku Kim, Seung Hyun Kim, Min-Soo Lee, Sook Haeng Joe, In Kwa Jung, Leen Kim

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: The cause of restless legs syndrome (RLS) is not yet clear, but more promising theories involve dopaminergic deficiency and genetic causes. This study investigated whether single-nucleotide polymorphisms in the genes of dopamine receptors DRD1, DRD2, DRD3 and DRD4 are associated with antipsychotics-induced RLS in schizophrenia. Methods: We evaluated 190 Korean schizophrenic patients using the diagnostic criteria of the International Restless Legs Syndrome Study Group and its rating scale for RLS. Genotyping was performed for the DRD1 gene -48A/G, DRD2 gene TaqI A, DRD3 gene Ser9Gly and DRD4 gene -521C/T single-nucleotide polymorphisms. The method of multifactor dimensionality reduction was used to analyze gene-gene interactions. Results: We classified the schizophrenic patients into 96 with and 94 without RLS symptoms. The genotype frequencies of all polymorphisms investigated did not differ significantly between these 2 groups. MDR analysis did not show a significant effect of the 4 dopamine receptor gene variants on susceptibility to antipsychotic-induced RLS symptoms (p > 0.05). Conclusions: These genetics data suggest that the analyzed polymorphisms of the dopamine genes may not be associated with RLS symptoms in schizophrenia. Confirming the results reported here requires a larger-scale study involving patients taking specific antipsychotics.

Original languageEnglish
Pages (from-to)49-54
Number of pages6
JournalNeuropsychobiology
Volume57
Issue number1-2
DOIs
Publication statusPublished - 2008 Jun 1

Fingerprint

Restless Legs Syndrome
Antipsychotic Agents
Dopamine
Schizophrenia
Genes
Dopamine Receptors
Single Nucleotide Polymorphism
Multifactor Dimensionality Reduction
Genotype

Keywords

  • Antipsychotics
  • Dopamine receptor genes, polymorphism
  • Restless legs syndrome
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)
  • Psychology(all)

Cite this

Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. / Kang, Seung Gul; Lee, Heon-Jeong; Choi, Jung Eun; Park, Young Min; Park, Jeong Hyun; Han, Changsu; Kim, Yong Ku; Kim, Seung Hyun; Lee, Min-Soo; Joe, Sook Haeng; Jung, In Kwa; Kim, Leen.

In: Neuropsychobiology, Vol. 57, No. 1-2, 01.06.2008, p. 49-54.

Research output: Contribution to journalArticle

@article{8c4c2a7cdce84fd89adbe4fc728d3172,
title = "Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia",
abstract = "Objective: The cause of restless legs syndrome (RLS) is not yet clear, but more promising theories involve dopaminergic deficiency and genetic causes. This study investigated whether single-nucleotide polymorphisms in the genes of dopamine receptors DRD1, DRD2, DRD3 and DRD4 are associated with antipsychotics-induced RLS in schizophrenia. Methods: We evaluated 190 Korean schizophrenic patients using the diagnostic criteria of the International Restless Legs Syndrome Study Group and its rating scale for RLS. Genotyping was performed for the DRD1 gene -48A/G, DRD2 gene TaqI A, DRD3 gene Ser9Gly and DRD4 gene -521C/T single-nucleotide polymorphisms. The method of multifactor dimensionality reduction was used to analyze gene-gene interactions. Results: We classified the schizophrenic patients into 96 with and 94 without RLS symptoms. The genotype frequencies of all polymorphisms investigated did not differ significantly between these 2 groups. MDR analysis did not show a significant effect of the 4 dopamine receptor gene variants on susceptibility to antipsychotic-induced RLS symptoms (p > 0.05). Conclusions: These genetics data suggest that the analyzed polymorphisms of the dopamine genes may not be associated with RLS symptoms in schizophrenia. Confirming the results reported here requires a larger-scale study involving patients taking specific antipsychotics.",
keywords = "Antipsychotics, Dopamine receptor genes, polymorphism, Restless legs syndrome, Schizophrenia",
author = "Kang, {Seung Gul} and Heon-Jeong Lee and Choi, {Jung Eun} and Park, {Young Min} and Park, {Jeong Hyun} and Changsu Han and Kim, {Yong Ku} and Kim, {Seung Hyun} and Min-Soo Lee and Joe, {Sook Haeng} and Jung, {In Kwa} and Leen Kim",
year = "2008",
month = "6",
day = "1",
doi = "10.1159/000129667",
language = "English",
volume = "57",
pages = "49--54",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "1-2",

}

TY - JOUR

T1 - Association study between antipsychotics-induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia

AU - Kang, Seung Gul

AU - Lee, Heon-Jeong

AU - Choi, Jung Eun

AU - Park, Young Min

AU - Park, Jeong Hyun

AU - Han, Changsu

AU - Kim, Yong Ku

AU - Kim, Seung Hyun

AU - Lee, Min-Soo

AU - Joe, Sook Haeng

AU - Jung, In Kwa

AU - Kim, Leen

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Objective: The cause of restless legs syndrome (RLS) is not yet clear, but more promising theories involve dopaminergic deficiency and genetic causes. This study investigated whether single-nucleotide polymorphisms in the genes of dopamine receptors DRD1, DRD2, DRD3 and DRD4 are associated with antipsychotics-induced RLS in schizophrenia. Methods: We evaluated 190 Korean schizophrenic patients using the diagnostic criteria of the International Restless Legs Syndrome Study Group and its rating scale for RLS. Genotyping was performed for the DRD1 gene -48A/G, DRD2 gene TaqI A, DRD3 gene Ser9Gly and DRD4 gene -521C/T single-nucleotide polymorphisms. The method of multifactor dimensionality reduction was used to analyze gene-gene interactions. Results: We classified the schizophrenic patients into 96 with and 94 without RLS symptoms. The genotype frequencies of all polymorphisms investigated did not differ significantly between these 2 groups. MDR analysis did not show a significant effect of the 4 dopamine receptor gene variants on susceptibility to antipsychotic-induced RLS symptoms (p > 0.05). Conclusions: These genetics data suggest that the analyzed polymorphisms of the dopamine genes may not be associated with RLS symptoms in schizophrenia. Confirming the results reported here requires a larger-scale study involving patients taking specific antipsychotics.

AB - Objective: The cause of restless legs syndrome (RLS) is not yet clear, but more promising theories involve dopaminergic deficiency and genetic causes. This study investigated whether single-nucleotide polymorphisms in the genes of dopamine receptors DRD1, DRD2, DRD3 and DRD4 are associated with antipsychotics-induced RLS in schizophrenia. Methods: We evaluated 190 Korean schizophrenic patients using the diagnostic criteria of the International Restless Legs Syndrome Study Group and its rating scale for RLS. Genotyping was performed for the DRD1 gene -48A/G, DRD2 gene TaqI A, DRD3 gene Ser9Gly and DRD4 gene -521C/T single-nucleotide polymorphisms. The method of multifactor dimensionality reduction was used to analyze gene-gene interactions. Results: We classified the schizophrenic patients into 96 with and 94 without RLS symptoms. The genotype frequencies of all polymorphisms investigated did not differ significantly between these 2 groups. MDR analysis did not show a significant effect of the 4 dopamine receptor gene variants on susceptibility to antipsychotic-induced RLS symptoms (p > 0.05). Conclusions: These genetics data suggest that the analyzed polymorphisms of the dopamine genes may not be associated with RLS symptoms in schizophrenia. Confirming the results reported here requires a larger-scale study involving patients taking specific antipsychotics.

KW - Antipsychotics

KW - Dopamine receptor genes, polymorphism

KW - Restless legs syndrome

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=45549088015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549088015&partnerID=8YFLogxK

U2 - 10.1159/000129667

DO - 10.1159/000129667

M3 - Article

C2 - 18451638

AN - SCOPUS:45549088015

VL - 57

SP - 49

EP - 54

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 1-2

ER -